Nestle India shares fell on Friday after FSSAI initiated three adjudication cases over alleged violations involving infant nutrition products. The regulator flagged promotional claims on NAN Excella Pro Stage 1 and Lactogen Pro 1 and also found a follow-up formula sample non-conforming for biotin content during laboratory testing.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.